Standard versus modified postural drainage in infants and young children with cystic fibrosis

  • Protocol
  • Intervention

Authors

  • Diana A Freitas,

    1. Federal University of Rio Grande do Norte, Department of Physiotherapy, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Fernando AL Dias,

    1. Federal University of Rio Grande do Norte, PhD Program in Physical Therapy, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Gabriela SS Chaves,

    1. Federal University of Rio Grande do Norte, Department of Physiotherapy, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Gardenia M H Ferreira,

    1. Federal University of Rio Grande do Norte, PhD Program in Physical Therapy, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Cibele TD Ribeiro,

    1. Federal University of Rio Grande do Norte, PhD Program in Physical Therapy, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Ricardo O Guerra,

    1. Federal University of Rio Grande do Norte, Department of Physiotherapy, Natal, Rio Grande do Norte, Brazil
    Search for more papers by this author
  • Karla MPP Mendonca

    Corresponding author
    1. Federal University of Rio Grande do Norte, Department of Physiotherapy, Natal, Rio Grande do Norte, Brazil
    • Karla MPP Mendonca, Department of Physiotherapy, Federal University of Rio Grande do Norte, Avenida Senador Salgado Filho, 3000, Bairro Lagoa Nova, Natal, Rio Grande do Norte, 59078-970, Brazil. kmorganna@ufrnet.br.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of standard postural drainage (greater (30° to 45° head down tilt) and lesser (15° to 20° head down tilt)) with modified postural drainage (without head down tilt) with regard to gastroesophageal reflux in infants and young children up to six years old with cystic fibrosis in terms of safety and efficacy.